经颈动脉血运重建结局不因患者年龄或性别而异
基于国际质量保证数据库2009年3月3日至2020年5月7日由1273名医师完成的18,240例经颈动脉血运重建(TCAR),女性占34.9%、有症状者占37.5%;校正后临床与技术复合不良事件发生率在女性与男性间、不同年龄组间均无显著差异,操作性能指标差异微小。
要点
- 女性与男性校正后临床复合不良事件率1.62% vs 1.35%(P=0.22),无显著差异。
- 女性与男性校正后技术复合不良事件率7.84% vs 7.80%(P=0.93),无显著差异。
- 女性校正后皮肤至皮肤时间76.6分钟短于男性77.7分钟(P=0.002)。
核心结论
- TCAR的临床和技术结局不受年龄或性别影响。
- 按年龄和性别分层时,操作性能指标存在临床轻微的差异。
- 除对年轻个体安全外,TCAR可能也是女性和老年患者(尤其是老年女性)行颈动脉支架置入的首选方法。
研究设计与样本
- 国际质量保证数据库收录2009年3月3日至2020年5月7日全球每位医师实施的全部TCAR手术。
- 共18,240例TCAR由1273名医师完成,女性占34.9%,有症状者占37.5%。
- 采用泊松回归评估年龄和性别对临床与技术复合不良事件发生率的影响,线性回归比较四项操作性能指标。
主要发现
- 校正后临床复合不良事件率女性1.62%(95%CI 1.17%-2.23%)vs 男性1.35%(95%CI 1.01%-1.79%),P=0.22。
- 校正后技术复合不良事件率女性7.84%(95%CI 6.85%-8.97%)vs 男性7.80%(95%CI 6.94%-8.77%),P=0.93。
- 校正后临床复合不良事件率随年龄变化无显著差异(P=0.65),技术复合不良事件率随年龄变化无显著差异(P=0.55)。
- 校正后皮肤至皮肤时间女性76.6分钟(95%CI 74.6-78.6)短于男性77.7分钟(95%CI 75.7-79.6),P=0.002。
- 按年龄组比较,透视时间、血流逆转时间和皮肤至皮肤时间存在显著差异,但差异幅度小(每项均<1分钟)。
关键数值与推荐
- 临床复合不良事件定义为术后24小时内死亡、卒中、短暂性脑缺血发作、心肌梗死。
- 技术复合不良事件定义为术后24小时内手术中止、中转开放手术、出血、夹层、颅神经损伤、器械失败。
- 四项操作性能指标为血流逆转时间、透视时间、对比剂用量和皮肤至皮肤时间。
临床怎么用
- 作者认为TCAR的临床和技术结局不受年龄或性别影响。
- 作者认为除对年轻个体安全外,TCAR可能也是女性和老年患者(尤其是老年女性)行颈动脉支架置入的首选方法。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Transcarotid artery revascularization (TCAR) is a hybrid approach to carotid revascularization. Limited information is available on the differences in periprocedural complications and performance measures of TCAR for men compared with women and for older vs younger adults. METHODS: The patient, lesion, and physician characteristics were collected for all TCAR procedures performed by each physician worldwide in an international quality assurance database between March 3, 2009 and May 7, 2020. Clinical composite (ie, death, stroke, transient ischemic attack, myocardial infarction) and technical composite (ie, aborted procedure, conversion to surgery, bleeding, dissection, cranial nerve injury, device failure) adverse events within 24 hours of the procedure were recorded. Four performance measures were recorded: flow-reversal time, fluoroscopy time, contrast volume, and skin-to-skin time. Poisson regressions were used to assess the effects of age and sex on the incidence of clinical and technical composite adverse events. Linear regressions were used to compare the four performance measures. RESULTS: A total of 18,240 TCARs were performed by 1273 physicians; 34.9% of the patients were women and 37.5% were symptomatic. The overall incidence of clinical and technical composite adverse events was low. The adjusted clinical (1.62% [95% confidence interval (CI), 1.17%-2.23%] vs 1.35% [95% CI, 1.01%-1.79%]; P = .22) and technical (7.84% [95% CI, 6.85%-8.97%] vs 7.80% [95% CI, 6.94%-8.77%]; P = .93) composite adverse event rates did not vary for women vs men. The adjusted clinical (P = .65) and technical (P = .55) composite adverse event rates also did not vary by age. The adjusted skin-to-skin time was shorter for the women (76.6 minutes; 95% CI, 74.6-78.6) than for the men (77.7 minutes; 95% CI, 75.7-79.6; P = .002). Significant differences were found by age group for fluoroscopy time, flow-reversal time, and skin-to-skin time, although the magnitude of these differences was small (<1 minute for each). CONCLUSIONS: The clinical and technical outcomes of TCAR are not affected by age or sex. We found clinically minor differences in the procedural performance measures when stratified by age and sex. In addition to being safe for younger individuals, TCAR could also be the preferred method for performing carotid stenting in women and older patients, in particular, older women.
引用
- Mayorga-Carlin M, Shaw P, Ozsvath K, et al. Transcarotid revascularization outcomes do not differ by patient age or sex. J Vasc Surg. 2022. PMID: 35358669. doi:10.1016/j.jvs.2022.01.141
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。